WCN24-1766 EFFECTS OF DAPAGLIFLOZIN IN PATIENTS WITH MEMBRANOUS NEPHROPATHY

WCN24-1766 EFFECTS OF DAPAGLIFLOZIN IN PATIENTS WITH MEMBRANOUS NEPHROPATHY

Saved in:

Bibliographic Details
Main Authors:	Hiddo J.L. Heerspink, David C. Wheeler, Ricardo Correa-Rotter, Jamie P. Dwyer, Anna Maria Langkilde, Patrick B. Mark, Michal Nowicki, Peter Rossing, Robert D. Toto, Glenn M. Chertow, Niels Jongs
Format:	Article
Language:	English
Published:	Elsevier 2024-04-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924004443
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

WCN24-1980 Efficacy and safety of zibotentan in combination with dapagliflozin in patients with CKD according to baseline diabetes status and kidney function
by: Hiddo Lambers Heerspink, et al.
Published: (2024-04-01)

WCN24-1550 ALDOSTERONE SYNTHASE INHIBITION WITH OR WITHOUT BACKGROUND SODIUM GLUCOSE COTRANSPORTER 2 INHIBITION IN CKD: A PHASE II CLINICAL TRIAL
by: Katherine Tuttle, et al.
Published: (2024-04-01)

WCN25-1898 IMPLICATIONS OF PROTEINURIA REMISSION ON ESTIMATED GLOMERULAR FILTRATION RATE (eGFR) TRAJECTORY IN PATIENTS (Pts) WITH IgA NEPHROPATHY (IgAN) IN PROTECT
by: Bruce Hendry, et al.
Published: (2025-02-01)

WCN24-1868 ASSIST: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CROSSOVER TRIAL OF ATRASENTAN IN PATIENTS WITH IGA NEPHROPATHY (IGAN) ON SGLT2I
by: Irene L. Noronha, et al.
Published: (2024-04-01)

WCN25-2620 CUMULATIVE EFFECTS OF THE ALDOSTERONE SYNTHASE INHIBITOR VICADROSTAT COMBINED WITH EMPAGLIFLOZIN ON ALBUMINURIA IN PEOPLE WITH CKD
by: Peter Rossing, et al.
Published: (2025-02-01)

Effects of dapagliflozin on podocyte damage and oxidative stress in patients with diabetic nephropathy
by: Yajing Shi, et al.
Published: (2025-08-01)

Pretreatment GFR Slopes Predict Dapagliflozin Response in IgA Nephropathy
by: Hiroyuki Ueda, et al.
Published: (2025-07-01)

WCN24-186 JAK/STAT EXPRESSION IN PATIENTS WITH IGA NEPHROPATHY
by: Mateus Luvizotto, et al.
Published: (2024-04-01)

Combination of dapagliflozin and pioglitazone lacks superiority against monotherapy in streptozotocin-induced nephropathy
by: Aneta Cinakova, et al.
Published: (2025-01-01)

WCN24-861 SUBCLINICAL RHABDOMYOLYSIS IN MESOAMERICAN NEPHROPATHY
by: Magdalena Madero, et al.
Published: (2024-04-01)

WCN24-1358 IL-1β and NLRP3 gene expression profile with dapagliflozin in inactive Lupus Nephritis
by: Gisele Vajgel, et al.
Published: (2024-04-01)

Zaludnienie parafii Szubin w roku 1766
by: Józef Matuszewski
Published: (2001-12-01)

WCN24-1863 Towards an IgA Nephropathy Atlas
by: Julio Saez-Rodriguez, et al.
Published: (2024-04-01)

WCN24-2099 BASELINE CHARACTERISTICS OF THE ALIGN TRIAL: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL OF ATRASENTAN IN PATIENTS WITH IGAN
by: Hiddo J.L. Heerspink, et al.
Published: (2024-04-01)

WCN24-2271 WARFARINRELATED NEPHROPATHY IN TWO PATIENTS WITH MECHANICAL VALVES
by: Hong Cheng, et al.
Published: (2024-04-01)

WCN24-1475 CLINICAL CHARACTERISTICS OF IGM NEPHROPATHY IN WESTERN MEXICO
by: Alejandro Garcia-Rivera, et al.
Published: (2024-04-01)

WCN24-2606 KIDNEY RE-BIOPSY IN ADULTS WITH IGA NEPHROPATHY
by: Leonel Langellotti, et al.
Published: (2024-04-01)

WCN24-2217 ACUTE PHOSPHATE NEPHROPATHY A CASE REPORT
by: Florencia Pucciariello, et al.
Published: (2024-04-01)

Using the International IgA Nephropathy Prediction Tool to Enrich Clinical Trial Cohorts
by: Sean J. Barbour, et al.
Published: (2025-04-01)

WCN24-1459 CRYSTALLINE LIGHT CHAIN NEPHROPATHY WITH COINCIDENTAL CAST NEPHROPATHY AND PROXIMAL TUBULOPATHY: CASE REPORT
by: Johanna Alvarez, et al.
Published: (2024-04-01)

WCN25-1572 DESIGN AND BASELINE CHARACTERISTICS OF THE GLOBAL KIDNEY PATIENT TRIALS NETWORK
by: Sradha Kotwal, et al.
Published: (2025-02-01)

The Necrotic Mystery of Dapagliflozin
by: Rida Naqvi, et al.
Published: (2025-06-01)

Dapagliflozin in Elderly Care
by: Sameer Angurana, et al.
Published: (2025-01-01)

WCN24-1061 ACUTE INTERSTITIAL NEPHROPATHY: CLINICAL-HISTOLOGICAL AND THERAPEUTIC ASPECTS
by: Nermine Ben Achour, et al.
Published: (2024-04-01)

WCN24-679 VANCOMYCIN ASSOCIATED CAST NEPHROPATHY: A CASE REPORT
by: Federico Ezra Dayan, et al.
Published: (2024-04-01)

WCN24-1807 POLYETHYLENE GLYCOL AS AN EXCIPIENT: UNCOMMON CAUSE OF OXALATE NEPHROPATHY
by: Omar Fueyo, et al.
Published: (2024-04-01)

WCN24-995 The Function and Mechanim of Prorenin Receptor (PRR) in Hypertensive Nephropathy
by: Mengjiao Lin, et al.
Published: (2024-04-01)

Status of the common myna Acridotheres tristis Linnaeus, 1766 in Turkey
by: E. Per
Published: (2022-01-01)

Study Design and Baseline Characteristics of ALIGN, a Randomized Controlled Study of Atrasentan in Patients With IgA Nephropathy
by: Hiddo J.L. Heerspink, et al.
Published: (2025-01-01)

WCN24-2238 EXOSTOSIN 1- AND 2- POSITIVE MEMBRANOUS NEPHROPATHY IN CHINESE PATIENTS
by: Hong Cheng, et al.
Published: (2024-04-01)

WCN24-2478 PODOCYTOPATHY ASSOCIATED WITH IGA NEPHROPATHY: IS IT REALLY A PROGNOSTIC FACTOR?
by: BELENGALLEGOS VAZQUEZ, et al.
Published: (2024-04-01)

WCN24-1802 Outcomes in patients with anticoagulant related nephropathy: from bad to worse
by: sergey brodsky, et al.
Published: (2024-04-01)

WCN24-1233 C1Q NEPHROPATHY IN CHILDREN: A CASE SERIES
by: Mayra Lorena Piton, et al.
Published: (2024-04-01)

First record of common Myna, Acridotheres tristis (Linnaeus, 1766) in Libya
by: Khaled Salem Etayeb, et al.
Published: (2025-02-01)

Complete mitochondrial genome and phylogenetic analysis of Podabacia crustacea (Pallas, 1766)
by: Caiyin Tang, et al.
Published: (2025-07-01)

Los nombramientos magisteriales del obispado de Michoacán, 1765-1766
by: María Guadalupe Cedeño Peguero
Published: (2024-11-01)

WCN24-1132 ACTION3 – Phase 3 study of DMX-200 for the treatment of focal segmental glomerulosclerosis (FSGS)
by: Jonathon Barratt, et al.
Published: (2024-04-01)

Kinetics of endothelin-1 and effect selective ETA antagonism on ETB activation: a mathematical modeling analysis
by: K. Melissa Hallow, et al.
Published: (2024-11-01)

WCN24-2320 ANALYSIS OF CLINICOPATHOLOGICAL CHARACTERISTICS OF MEMBRANOUS NEPHROPATHY WITH CONCOMITANT MALIGNANCY AND LITERATURE REVIEW
by: Hong Cheng, et al.
Published: (2024-04-01)

WCN24-2006 OXALATE NEPHROPATHY SECONDARY TO GASTRIC BYPASS SURGERY: A CASE REPORT
by: Manuel Hernandez, et al.
Published: (2024-04-01)